J. Scott Wolchko
2017
In 2017, J. Scott Wolchko earned a total compensation of $1.3M as President, Chief Executive Officer and Director at Fate Therapeutics, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $156,000 |
|---|---|
| Option Awards | $668,789 |
| Salary | $480,000 |
| Total | $1,304,789 |
Wolchko received $668.8K in option awards, accounting for 51% of the total pay in 2017.
Wolchko also received $156K in non-equity incentive plan and $480K in salary.
Rankings
In 2017, J. Scott Wolchko's compensation ranked 7,704th out of 14,666 executives tracked by ExecPay. In other words, Wolchko earned more than 47.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,704 out of 14,666 | 48th |
Division Manufacturing | 2,883 out of 5,768 | 50th |
Major group Chemicals And Allied Products | 937 out of 2,074 | 55th |
Industry group Drugs | 724 out of 1,730 | 58th |
Industry Biological Products, Except Diagnostic Substances | 138 out of 316 | 56th |
Source: SEC filing on March 16, 2018.
Wolchko's colleagues
We found two more compensation records of executives who worked with J. Scott Wolchko at Fate Therapeutics in 2017.